by Kinnate Biopharma | Sep 12, 2020
This is a placeholder. It's hidden from the grid/chart , but necessary to display the filter option until real projects have this category. Keep the category "Hidden"...
by Kinnate Biopharma | Sep 12, 2020
This is a placeholder. It's hidden from the grid/chart , but necessary to display the filter option until real projects have this category. Keep the category "Hidden"...
by Kinnate Biopharma | Sep 12, 2020
This is a placeholder. It's hidden from the grid/chart , but necessary to display the filter option until real projects have this category. Keep the category "Hidden"...
by Kinnate Biopharma | Sep 12, 2020
We are actively engaged in discovery-stage programs investigating multiple undisclosed programs targeting key molecular drivers in...
by Kinnate Biopharma | Sep 12, 2020
We are also advancing a number of other small molecule development programs, including a CDK12 inhibitor. CDK12 is an essential regulator of DNA damage response genes against which no targeted therapies are currently approved or, to our knowledge, in clinical...
Recent Comments